Magazine Article | June 1, 2023

Leading Aulos Bioscience's "Triumvirate" Model

Source: Life Science Leader

By Ben Comer, Chief Editor, Life Science Leader

During the peak COVID-19 danger days of late 2020, a VC firm headquartered in New York City and a platform antibody company in Israel conceived a California-based immuno-oncology drug developer named Aulos Bioscience.

access the Magazine Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests: